Please assess the completion status of the following clinical trial:

Trial Title: Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* HIV-1 positive patients who have maintained an HIV-1 viral load \<200 copies/mL, for at least 3 months.~* Patients must be on their first HAART or have documented viral suppression on a PI-based regimen at the time of any prior change in therapy.~* HAART must consist of either:~  1. A PI (with or without ritonavir) + at least 2 NRTIs or~ 2. An NNRTI + at least 2 NRTIs.~* Negative serum pregnancy test.~Exclusion Criteria:~* Patients who have taken any NNRTI prior to their current therapy.~* Patients who have taken a NRTI-only therapy for greater than 7 days prior to their current therapy.~* Patients who are currently taking EFV+FTC+TDF.~* Patients who have a creatinine clearance of \<60 mL/min by Cockcroft-Gault estimation.~* Patients who have experienced virologic failure with any previous ARV therapy.~* Patients who have documented resistance to any of the study agents at any time in the past.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).